{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:52:54Z","timestamp":1793321574507,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111630","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:20:36Z","timestamp":1707178836000},"page":"111630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ferritin-binding and ubiquitination-modified mRNA vaccines induce potent immune responses and protective efficacy against SARS-CoV-2"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9463-9085","authenticated-orcid":false,"given":"Tong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChenChao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunHong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiQiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaXin","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5406-0503","authenticated-orcid":false,"given":"SongHui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RenYue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaFeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NingYi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingYao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111630_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2020.08.011","article-title":"The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies","volume":"551","author":"Seyed Hosseini","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2024.111630_bib167","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.111630_bib168","first-page":"21","article-title":"mRNA vaccine era-mechanisms, drug platform and clinical prospection","author":"Xu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111630_bib169","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.111630_bib170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmii.2022.12.003","article-title":"Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan","volume":"56","author":"Wu","year":"2023","journal-title":"Journal of microbiology, immunology, and infection =, Wei Mian Yu Gan Ran Za Zhi"},{"key":"10.1016\/j.intimp.2024.111630_bib171","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jiph.2021.12.014","article-title":"The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges","volume":"15","author":"Malik","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.intimp.2024.111630_bib172","first-page":"23","article-title":"A Vaccine of SARS-CoV-2 S Protein RBD induces protective immunity","author":"Qu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111630_bib173","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1056\/NEJMc2216233","article-title":"Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines","volume":"388","author":"Li","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.111630_bib174","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41467-023-37417-9","article-title":"A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates","volume":"14","author":"Weidenbacher","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.111630_bib175","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211491","article-title":"Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs","volume":"41","author":"Thura","year":"2021","journal-title":"Bioscience reports"},{"key":"10.1016\/j.intimp.2024.111630_bib176","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11262-004-4586-9","article-title":"Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates","volume":"30","author":"Zhu","year":"2005","journal-title":"Virus Genes"},{"key":"10.1016\/j.intimp.2024.111630_bib177","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.111630_bib178","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2024.111630_bib179","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2024.111630_bib180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.intimp.2024.111630_bib181","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.111630_bib182","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2024.111630_bib183","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: what, why and how","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2024.111630_bib184","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.111630_bib185","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1016\/j.vaccine.2021.10.074","article-title":"BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity","volume":"39","author":"Vizcarra","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2024.111630_bib186","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Therapy\u202f: J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.intimp.2024.111630_bib187","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.111630_bib188","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jiph.2022.03.017","article-title":"SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review","volume":"15","author":"Malik","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.intimp.2024.111630_bib189","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining \u2018host jump\u2019 of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.intimp.2024.111630_bib190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.celrep.2018.06.041","article-title":"Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV Spike Glycoprotein","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.intimp.2024.111630_bib191","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.111630_bib192","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00775-016-1336-0","article-title":"Ferritins: furnishing proteins with iron","volume":"21","author":"Bradley","year":"2016","journal-title":"J. Biol. Inorganic Chem.: JBIC\u202f: a Publicat. Soc. Biol. Inorgan. Chem."},{"key":"10.1016\/j.intimp.2024.111630_bib193","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.111630_bib194","doi-asserted-by":"crossref","first-page":"eabi5735","DOI":"10.1126\/scitranslmed.abi5735","article-title":"A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates","volume":"14","author":"Joyce","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.111630_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007640","article-title":"The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis","volume":"15","author":"Langerak","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.intimp.2024.111630_bib196","article-title":"Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies","volume":"100666","author":"Reinig","year":"2023","journal-title":"Biomedical Journal"},{"key":"10.1016\/j.intimp.2024.111630_bib197","first-page":"e23","article-title":"Understanding the T cell immune response in SARS coronavirus infection, Emerging Microbes","volume":"1","author":"Janice","year":"2012","journal-title":"Infect"},{"key":"10.1016\/j.intimp.2024.111630_bib198","article-title":"Mapping and role of T cell response in SARS-CoV-2-infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"The Journal of Experimental Medicine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:41:43Z","timestamp":1769229703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924001486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"alternative-id":["S1567576924001486"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111630","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferritin-binding and ubiquitination-modified mRNA vaccines induce potent immune responses and protective efficacy against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111630"}}